Hyperalgesia due to nerve damage: Role of nerve growth factor

Pain

Volumn 81, Issue 3, 1999, Pages 245-255

  Theodosiou, M ^a   Rush, R A ^b   Zhou, X F ^b   Hu, D ^a   Walker, J S ^a   Tracey, D J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Brain derived neurotrophic factor; Hyperalgesia; Mast cells; Nerve growth factor; Peripheral neuropathy; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; ANTISERUM; BRAIN DERIVED NEUROTROPHIC FACTOR; KETANSERIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; SEROTONIN; SEROTONIN ANTAGONIST; TROPISETRON;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; MALE; MAST CELL; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; HUMANS; HYPERALGESIA; IMMUNE SERA; IMMUNIZATION, PASSIVE; INDOLES; KETANSERIN; MALE; MAST CELLS; NERVE GROWTH FACTORS; NEUROTROPHIN 3; NOCICEPTORS; PERIPHERAL NERVES; RATS; RATS, WISTAR; SCIATIC NERVE; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0033062685     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00018-4     Document Type: Article

References (71)

1. Abbott F.V., Hong Y., Blier P. Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 35:1996;99-110.
2. Aloe L., Tuveri M.A., Levi-Montalcini R. Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol. Int. 12:1992;213-216.
3. Amann R., Schuligoi R., Herzeg G., Donnerer J. Intraplantar injection of nerve growth factor into the rat hind paw: Local edema and effects on thermal nociceptive threshold. Pain. 64:1996;323-329.
4. Andreev N.Y., Dimitrieva N., Koltzenburg M., McMahon S.B. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain. 63:1995;109-115.
5. Apfel S.C., Wright D.E., Wiideman A.M., Dormia C., Snider W.D., Kessler J.A. Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system. Mol. Cell. Neurosci. 7:1996;134-142.
6. Averill S., McMahon S.B., Clary D.O., Reichardt L.F., Priestley J.V. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur. J. Neurosci. 7:1995;1484-1494.
7. Bennett D.L., French J., Priestley J.V., McMahon S.B. NGF but not NT-3 or BDNF prevents the A fiber sprouting into lamina II of the spinal cord that occurs following axotomy. Mol. Cell. Neurosci. 8:1996;211-220.
8. Cardenas, C.G., Del Mar, L.P., Cooper, B.Y. and Scroggs, R.S., 5HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons, J. Neurosci., 17 (1997a) 7181-7189.
9. Cardenas, C.G., Del Mar, L.P. and Scroggs, R.S., Two parallel signalling pathways couple 5HT1A receptors to N- and L-type calcium channels in C-like rat dorsal root ganglion cells, J. Neurophysiol., 77 (1997b) 3284-3296.
10. Carroll P., Lewin G.R., Koltzenburg M., Toyka K.V., Thoenen H. A role for BDNF in mechanosensation. Nature Neurosci. 1:1998;42-46.
11. Cho H.J., Kim J.K., Zhou X.F., Rush R.A. Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res. 764:1997;269-272.
12. Clatworthy A.L., Illich P.A., Castro G.A., Walters E.T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184:1995;5-8.
13. Coderre T.J., Basbaum A.I., Levine J.D. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J. Neurophysiol. 62:1989;48-58.
14. Conway, S.R., Postraumatic neuralgias. In: C.A. Warfield (Ed.), Manual of Pain Management, J.B. Lippincott, Phildadelphia, 1991, p. 204.
15. Davis B.M., Lewin G.R., Mendell L.M., Jones M.E., Albers K.M. Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli. Neurosci. 56:1993;789-792.
16. Enerbäck L., Olsson Y., Sourander P. Mast cells in normal and sectioned peripheral nerve. Zeitschrift für Zellforsch. 66:1965;596-608.
17. Eschalier A., Kayser V., Guilbaud G. Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats. Pain. 36:1989;249-255.
18. Fagan A.M., Zhang H., Landis S., Smeyne R.J., Silos-Santiago I., Barbacid M. TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J. Neurosci. 16:1996;6208-6218.
19. Frade J.M., Barde Y.A. Nerve growth factor: two receptors, multiple functions. Bioessays. 20:1998;137-145.
20. Fuller G.N., Jacobs J.M., Guiloff R.J. Nature and incidence of peripheral nerve syndromes in HIV infection. J. Neurol. Neurosurg. Psychiatry. 56:1993;372-381.
21. Giordano J., Sacks S.M. Sub-anesthetic doses of bupivacaine or lidocaine increase peripheral ICS-205 930-induced analgesia against inflammatory pain in rats. Eur. J. Pharmacol. 334:1997;39-41.
22. Glennon R.A., Naiman N.A., Lyon R.A., Titeler M. Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands. J. Med. Chem. 31:1988;1968-1971.
23. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
24. Herzberg U., Eliav E., Dorsey J.M., Gracely R.H., Kopin I.J. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. NeuroReport. 8:1997;1613-1618.
25. Heumann R., Korsching S., Bandtlow C., Thoenen H. Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection. J. Cell Biol. 104:1987;1623-1631.
26. Hong Y., Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience. 63:1994;827-836.
27. Horigome K., Pryor J.C., Bullock E.D., Johnson E.M. Jr. Mediator release from mast cells by nerve growth factor, Neurotrophin specificity and receptor mediation. J. Biol. Chem. 268:1993;14881-14887.
28. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-129.
29. Lewin G.R. Neurotrophic factors and pain. Semin. Neurosci. 7:1995;227-232.
30. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13:1993;2136-2148.
31. Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6:1994;1903-1912.
32. Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 330:1987;658-659.
33. Marshall J.S., Waserman S. Mast cells and the nerves-potential interactions in the context of chronic disease. Clin. Exp. Allergy. 25:1995;102-110.
34. Martínez-Gómez M., Cruz Y., Salas M., Hudson R., Pacheco P. Assessing pain threshold in the rat: changes with estrus and time of day. Physiol. Behav. 55:1994;651-657.
35. Mazurek N., Weskamp G., Erne P., Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 198:1986;315-320.
36. McMahon S.B. NGF as a mediator of inflammatory pain. Philos. Trans. R. Soc. Lond. (Biol.). 351:1996;431-440.
37. McMahon S.B., Bennett D.L.H., Priestley J.V., Shelton D.L. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nature Med. 1:1995;774-780.
38. Metzler C.M., Elfring G.L., McEwen A.J. A user's manual for NONLIN and associated programs. Biometrics. 30:1974;562.
39. Mobley W.C., Schenker A., Shooter E.M. Characterization and isolation of proteolytically modified nerve growth factor. Biochem. J. 15:1976;5543-5552.
40. Pierce P.A., Xie G.X., Levine J.D., Peroutka S.J. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience. 70:1996;553-559.
41. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111:1957;409-419.
42. Ren K., Thomas D.A., Dubner R. Nerve growth factor alleviates a painful peripheral neuropathy in rats. Brain Res. 699:1995;286-292.
43. Ro L.S., Jacobs J.M. The role of the saphenous nerve in experimental sciatic nerve mononeuropathy produced by loose ligatures: a behavioural study. Pain. 52:1993;359-369.
44. Rueff A., Dawson A.J.L.R., Mendell L.M. Characteristics of nerve growth factor induced hyperalgesia in adult rats: dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain. 66:1996;359-372.
45. Rueff A., Dray A. Pharmacological characterization of the effects of 5-hydroxytryptamine and different prostaglandins on peripheral sensory neurons in vitro. Agents Actions. 38:1993;C13-C15.
46. Rueff A., Mendell L.M. Nerve growth factor and NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J. Neurophysiol. 76:1996;3593-3596.
47. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115:1995;1265-1275.
48. Sanford J., Ewbank R., Molony V., Tavernor W.D., Uvarov O. Guidelines for the recognition and assessment of pain in animals. Vet. Rec. 118:1986;334-338.
49. Scadding, J.W., Peripheral neuropathies. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, Edinburgh, 1994, pp. 667-683.
50. Schepelmann K., Messlinger K., Schaible H.G., Schmidt R.F. Inflammatory mediators and nociception in the joint: excitation and sensitization of slowly conducting afferent fibers of cat's knee by prostaglandin I2. Neurosci. 50:1992;237-247.
51. Schmauder-Chock E.A., Chock S.P. Localization of cyclo-oxygenase and prostaglandin E2 in the secretory granule of the mast cell. J. Histochem. Cytochem. 37:1989;1319-1328.
52. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
53. Simone D.A. Neural mechanisms of hyperalgesia. Curr. Opin. Neurobiol. 2:1992;479-483.
54. Strobel S., Miller H.R., Ferguson A. Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J. Clin. Pathol. 34:1981;851-858.
55. Taiwo Y.O., Heller P.H., Levine J.D. Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience. 48:1992;479-483.
56. Taiwo Y.O., Levine J.D. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res. 537:1990;372-374.
57. Taiwo Y.O., Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 48:1992;485-490.
58. Tal M., Liberman R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci. Lett. 221:1997;129-132.
59. Tracey D.J., Romm M.A., Yao N.N.L. Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y. Brain Res. 669:1995;245-254.
60. Tracey D.J., Walker J.S. Pain due to nerve damage: are inflammatory mediators involved? Inflamm. Res. 44:1995;407-411.
61. Van Nueten J.M., Janssen P.A., Van Beek J., Xhonneux R., Verbeuren T.J., Vanhoutte P.M. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J. Pharmacol. Exp. Ther. 218:1981;217-230.
62. Verge V.M., Gratto K.A., Karchewski L.A., Richardson P.M. Neurotrophins and nerve injury in the adult, Phil. Trans. R. Soc. Lond. B. Biol. Sci. 351:1996;423-430.
63. Verge V.M., Richardson P.M., Benoit R., Riopelle R.J. Histochemical characterization of sensory neurons with high-affinity receptors for nerve growth factor. J. Neurocytol. 18:1989;583-591.
64. Vinegar R., Truax J.F., Selph J.L., Johnston P.R. Pharmacological characterization of the algesic response to the subplantar injection of serotonin in the rat. Eur. J. Pharmacol. 164:1989;497-505.
65. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 48:1987;1779-1786.
66. Woolf C.J., Doubell T.P. The pathophysiology of chronic pain - increased sensitivity to low threshold A beta-fibre inputs. Curr. Opin. Neurobiol. 4:1994;525-534.
67. Woolf C.J., Ma Q.P., Allchorne A., Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J. Neurosci. 16:1996;2716-2723.
68. Woolf C.J., Safieh-Garabedian B., Ma Q.P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 62:1994;327-331.
69. Yoshida N., Mizumoto A., Iwanaga Y., Itoh Z. Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs. J. Pharmacol. Exper. Ther. 256:1991;272-278.
70. Zhou X.F., Rush R.A. Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience. 74:1996;945-951.
71. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.